Galenica Sante (Switzerland) Performance
| GALE Stock | CHF 76.50 0.35 0.46% |
Galenica Sante has a performance score of 5 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.0616, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Galenica Sante's returns are expected to increase less than the market. However, during the bear market, the loss of holding Galenica Sante is expected to be smaller as well. Galenica Sante AG right now retains a risk of 0.86%. Please check out Galenica Sante coefficient of variation, jensen alpha, sortino ratio, as well as the relationship between the information ratio and total risk alpha , to decide if Galenica Sante will be following its current trending patterns.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Galenica Sante AG are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Galenica Sante is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 59.8 M | |
| Total Cashflows From Investing Activities | -88.2 M |
Galenica |
Galenica Sante Relative Risk vs. Return Landscape
If you would invest 7,355 in Galenica Sante AG on August 29, 2024 and sell it today you would earn a total of 295.00 from holding Galenica Sante AG or generate 4.01% return on investment over 90 days. Galenica Sante AG is generating 0.0651% of daily returns and assumes 0.8637% volatility on return distribution over the 90 days horizon. Simply put, 7% of stocks are less volatile than Galenica, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Galenica Sante Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Galenica Sante's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Galenica Sante AG, and traders can use it to determine the average amount a Galenica Sante's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0754
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | GALE | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 0.86 actual daily | 7 93% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 5 95% of assets perform better |
Based on monthly moving average Galenica Sante is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Galenica Sante by adding it to a well-diversified portfolio.
Galenica Sante Fundamentals Growth
Galenica Stock prices reflect investors' perceptions of the future prospects and financial health of Galenica Sante, and Galenica Sante fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Galenica Stock performance.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0492 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 4.26 B | |||
| Shares Outstanding | 49.64 M | |||
| Price To Earning | 16.37 X | |||
| Price To Book | 3.16 X | |||
| Price To Sales | 0.94 X | |||
| Revenue | 3.83 B | |||
| EBITDA | 305.98 M | |||
| Cash And Equivalents | 164.98 M | |||
| Cash Per Share | 2.13 X | |||
| Total Debt | 579.88 M | |||
| Debt To Equity | 43.80 % | |||
| Book Value Per Share | 23.35 X | |||
| Cash Flow From Operations | 333.1 M | |||
| Earnings Per Share | 3.45 X | |||
| Total Asset | 2.57 B | |||
About Galenica Sante Performance
Evaluating Galenica Sante's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Galenica Sante has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Galenica Sante has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Galenica AG operates as a healthcare provider in Switzerland and internationally. The company was incorporated in 2017 and is headquartered in Bern, Switzerland. Galenica Sant operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 77 people.Things to note about Galenica Sante AG performance evaluation
Checking the ongoing alerts about Galenica Sante for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Galenica Sante AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Galenica Sante's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Galenica Sante's stock performance include:- Analyzing Galenica Sante's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Galenica Sante's stock is overvalued or undervalued compared to its peers.
- Examining Galenica Sante's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Galenica Sante's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Galenica Sante's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Galenica Sante's stock. These opinions can provide insight into Galenica Sante's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Galenica Stock Analysis
When running Galenica Sante's price analysis, check to measure Galenica Sante's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galenica Sante is operating at the current time. Most of Galenica Sante's value examination focuses on studying past and present price action to predict the probability of Galenica Sante's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galenica Sante's price. Additionally, you may evaluate how the addition of Galenica Sante to your portfolios can decrease your overall portfolio volatility.